Aurelie Hanoteau

发表

Cyclophosphamide treatment induces rejection of established P815 mastocytoma by enhancing CD4 priming and intratumoral infiltration of P1E/H‐2Kd‐specific CD8+ T cells

C. Mackay, M. Moser, D. Colau, 2014, International journal of cancer.

TGF-β1 programmed myeloid-derived suppressor cells (MDSC) acquire immune-stimulating and tumor killing activity capable of rejecting established tumors in combination with radiotherapy

D. Edwards, K. Rajapakshe, C. Coarfa, 2018, Oncoimmunology.

Chemotherapy and immunotherapy: A close interplay to fight cancer?

M. Moser, Aurelie Hanoteau, 2016, Oncoimmunology.

Cyclophosphamide treatment regulates the balance of functional/exhausted tumor-specific CD8+ T cells

P. Romero, M. Moser, O. Leo, 2017, Oncoimmunology.

Tumor microenvironment modulation enhances immunologic benefit of chemoradiotherapy

S. H. van der Burg, C. Melief, Chen Huang, 2019, Journal of Immunotherapy for Cancer.

Immune microenvironment modulation unmasks therapeutic benefit of radiotherapy and checkpoint inhibition

A. Sikora, J. V. Van Ginderachter, D. Laoui, 2019, Journal of Immunotherapy for Cancer.

Anti-tumor immunity induced by ectopic expression of viral antigens is transient and limited by immune escape

Aileen W. Li, D. Mooney, L. Golfman, 2019, Oncoimmunology.

Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors.

A. Sikora, J. Newton, Aurelie Hanoteau, 2018, Journal of visualized experiments : JoVE.

Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors.

A. Sikora, J. Newton, Aurelie Hanoteau, 2018, Journal of visualized experiments : JoVE.